Cheminformatic Tools and Databases for Pharmacology

session 90243 - Total of 2 hits - Display   hits per page:

Add another drug(s) by one keyword:
Exemple: “nib“ and click on the Search button (do not press Enter on the keyboard)

1 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
IXAZOMIB (is an active metabolite)

IXAZOMIB


ATC L01XG03

ANTINEOPLASTIC
TREATMENT OF MULTIPLE MYELOMA
PROTEASOME INHIBITOR
PRODRUG OF IXAZOMIB
CHYMOTRYPSIN-LIKE ACTIVITY OF THE BETA 5 SUBUNIT OF THE 20S PROTEASOME

-

Tmax 1 HOUR

F 58 PERCENT

VD 543 LITER

PPB 99 PERCENT

Cl 1.9 LITER / HOUR

HT 228 HOUR

20S PROTEASOME

PDB 5LF7 (HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM)

LIGAND CODE = 6V8 (link to the list of PDB complexes)

Download experimental 3D coordinates of 6V8 with added hydrogens

Proteasome subunit beta type-5 UNIPROT P28074 PSMB5

more at DrugCentral

EMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank

2 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
IXAZOMIB CITRATE (has an active metabolite)

IXAZOMIB CITRATE


ATC L01XG03

ANTINEOPLASTIC
TREATMENT OF MULTIPLE MYELOMA
PROTEASOME INHIBITOR
PRODRUG OF IXAZOMIB
CHYMOTRYPSIN-LIKE ACTIVITY OF THE BETA 5 SUBUNIT OF THE 20S PROTEASOME

ORAL 20S PROTEASOME

Proteasome subunit beta type-5 UNIPROT P28074 PSMB5

more at DrugCentral

EMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank



Copyright © 2019 Université Côte d'Azur CNRS - All rights reserved
  | Contact |